Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Livermore

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
International Journal of Antimicrobial Agents|August 3, 2007
Introduction: the challenge of multiresistanceDavid M Livermore
Diagnostic Microbiology and Infectious Disease|March 24, 2009
Doripenem: antimicrobial profile and clinical potentialDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Future directions with daptomycinDavid M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 2011
Discovery research: the scientific challenge of finding new antibioticsDavid M Livermore,
Annals of Medicine|July 9, 2003
The threat from the pink cornerDavid M Livermore
Current Protein & Peptide Science|June 23, 2009
beta-Lactamases- the Threat RenewsDavid M Livermore
The Journal of Antimicrobial Chemotherapy|August 14, 2009
Has the era of untreatable infections arrived?David M Livermore
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The impact of carbapenemases on antimicrobial development and therapyDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 24, 2018
The 2018 Garrod Lecture: Preparing for the Black Swans of resistanceDavid M Livermore
The Korean Journal of Internal Medicine|June 19, 2012
Current epidemiology and growing resistance of gram-negative pathogensDavid M Livermore
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
International Journal of Antimicrobial Agents|August 3, 2007
Introduction: the challenge of multiresistanceDavid M Livermore
Diagnostic Microbiology and Infectious Disease|March 24, 2009
Doripenem: antimicrobial profile and clinical potentialDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Future directions with daptomycinDavid M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 2011
Discovery research: the scientific challenge of finding new antibioticsDavid M Livermore,
Annals of Medicine|July 9, 2003
The threat from the pink cornerDavid M Livermore
Current Protein & Peptide Science|June 23, 2009
beta-Lactamases- the Threat RenewsDavid M Livermore
The Journal of Antimicrobial Chemotherapy|August 14, 2009
Has the era of untreatable infections arrived?David M Livermore
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The impact of carbapenemases on antimicrobial development and therapyDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 24, 2018
The 2018 Garrod Lecture: Preparing for the Black Swans of resistanceDavid M Livermore
The Korean Journal of Internal Medicine|June 19, 2012
Current epidemiology and growing resistance of gram-negative pathogensDavid M Livermore
Pageof 27